title: Results of a changing treatment philosophy for children with stage I Hodgkin's disease: a 35-year experience.
abstract: Over the last four decades, significant changes have occurred in the management of childhood stage I Hodgkin's disease. Between 1949 and 1984, 50 children, ages 4 to 16 years, were treated for stage I Hodgkin's disease at The University of Texas M. D. Anderson Cancer Center. Nineteen children had clinically staged (CS) disease. Thirty-one patients were pathologically staged (PS). Thirty-four children were treated with radiotherapy only, 12 were treated with both radiotherapy and chemotherapy, and 3 patients were treated with combination chemotherapy alone. All patients were followed from 32 to 311 months (median 170 months). Five-, 10-, and 15-year actuarial survival rates for all patients were 94, 89, and 84%, respectively. The corresponding freedom from relapse (FFR) rates were 76, 69, and 69% respectively. The 10-year actuarial survival and FFR rates for CS patients were 79 and 42%. The corresponding rates for PS patients were 97 and 86%. In patients with PSI disease, actuarial 10-year FFR rates of 100% were obtained either with regional radiotherapy alone or with combination chemotherapy and involved field radiotherapy. The following delayed adverse effects of treatment were observed: growth abnormalities in 17, aspermia in 3, thyroid abnormalities in 11 (two carcinomas), and second malignancies beyond the radiotherapy fields in 2. We conclude with a recommendation of combined chemotherapy and involved field radiation for children who have not fulfilled their growth potential, to achieve high cure rates, while minimizing morbidity.
authors.affiliation: Department of Clinical Radiotherapy, University of Texas M.D. Anderson Cancer Center, Houston 77030.
authors.forename: A S
authors.initials: AS
authors.lastname: Garden
authors.forename: S Y
authors.initials: SY
authors.lastname: Woo
authors.forename: L M
authors.initials: LM
authors.lastname: Fuller
authors.forename: M P
authors.initials: MP
authors.lastname: Sullivan
authors.forename: I
authors.initials: I
authors.lastname: Ramirez
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006128:Growth / Q000528:radiation effects; D006130:Growth Disorders / Q000209:etiology; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011832:Radiation Injuries; D012008:Recurrence; D015996:Survival Rate